RVTY

#868
Revvity, Inc.
93.7100 USD
+0.15%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
93.7100
94.3500
年范围
83.4800
118.2600
日变化
+0.15%
每月变动
+8.37%
6个月变化
-1.21%
年变化
-1.21%
前一天收盘价
93.5700
开盘价
94.0900
买价
卖价
最低价
93.7100
High
94.3500
交易量
84
展开完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 10.4767 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
46.91
市销率
3.96
每股股息
0.28
股息收益率 %
0.29

Revvity Inc

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

新闻